JP2015532923A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015532923A5 JP2015532923A5 JP2015533048A JP2015533048A JP2015532923A5 JP 2015532923 A5 JP2015532923 A5 JP 2015532923A5 JP 2015533048 A JP2015533048 A JP 2015533048A JP 2015533048 A JP2015533048 A JP 2015533048A JP 2015532923 A5 JP2015532923 A5 JP 2015532923A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- tissue
- antibiotic
- ecm
- component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 claims 3
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 claims 3
- 210000002744 extracellular matrix Anatomy 0.000 claims 3
- 210000001519 tissue Anatomy 0.000 claims 3
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 claims 2
- 230000003115 biocidal effect Effects 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- CFGDUGSIBUXRMR-UHFFFAOYSA-N 1,2-dihydropyrrol-2-ide Chemical compound C=1C=[C-]NC=1 CFGDUGSIBUXRMR-UHFFFAOYSA-N 0.000 claims 1
- WZRJTRPJURQBRM-UHFFFAOYSA-N 4-amino-n-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide;5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1.COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 WZRJTRPJURQBRM-UHFFFAOYSA-N 0.000 claims 1
- 229930186147 Cephalosporin Natural products 0.000 claims 1
- 229930182555 Penicillin Natural products 0.000 claims 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims 1
- 239000004098 Tetracycline Substances 0.000 claims 1
- 108010059993 Vancomycin Proteins 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
- 229940126575 aminoglycoside Drugs 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 239000012867 bioactive agent Substances 0.000 claims 1
- 229940124587 cephalosporin Drugs 0.000 claims 1
- 150000001780 cephalosporins Chemical class 0.000 claims 1
- 229960005091 chloramphenicol Drugs 0.000 claims 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 claims 1
- 229960002227 clindamycin Drugs 0.000 claims 1
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 claims 1
- 229940047766 co-trimoxazole Drugs 0.000 claims 1
- 230000002526 effect on cardiovascular system Effects 0.000 claims 1
- 229960003276 erythromycin Drugs 0.000 claims 1
- 229940124307 fluoroquinolone Drugs 0.000 claims 1
- 210000005003 heart tissue Anatomy 0.000 claims 1
- 239000007972 injectable composition Substances 0.000 claims 1
- 239000003120 macrolide antibiotic agent Substances 0.000 claims 1
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 claims 1
- 229960000282 metronidazole Drugs 0.000 claims 1
- 229940049954 penicillin Drugs 0.000 claims 1
- 229960002180 tetracycline Drugs 0.000 claims 1
- 229930101283 tetracycline Natural products 0.000 claims 1
- 235000019364 tetracycline Nutrition 0.000 claims 1
- 150000003522 tetracyclines Chemical class 0.000 claims 1
- MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 claims 1
- 229960003165 vancomycin Drugs 0.000 claims 1
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/573,569 | 2012-09-24 | ||
| US13/573,569 US9072816B2 (en) | 2006-01-18 | 2012-09-24 | Composition for modulating inflammation of cardiovascular tissue |
| PCT/US2013/046039 WO2014046752A1 (en) | 2012-09-24 | 2013-06-15 | Method and system for treatment of biological tissue |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015532923A JP2015532923A (ja) | 2015-11-16 |
| JP2015532923A5 true JP2015532923A5 (enExample) | 2016-07-28 |
Family
ID=50342519
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015533045A Pending JP2015532922A (ja) | 2012-09-24 | 2013-05-29 | 生体組織の治療のための方法及びシステム |
| JP2015533049A Pending JP2015531664A (ja) | 2012-09-24 | 2013-06-14 | 生体組織の治療のための方法及びシステム |
| JP2015533048A Pending JP2015532923A (ja) | 2012-09-24 | 2013-06-15 | 生体組織の治療のための方法及びシステム |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015533045A Pending JP2015532922A (ja) | 2012-09-24 | 2013-05-29 | 生体組織の治療のための方法及びシステム |
| JP2015533049A Pending JP2015531664A (ja) | 2012-09-24 | 2013-06-14 | 生体組織の治療のための方法及びシステム |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US9072816B2 (enExample) |
| EP (3) | EP2887948A4 (enExample) |
| JP (3) | JP2015532922A (enExample) |
| CN (1) | CN104703614A (enExample) |
| AU (3) | AU2013318632A1 (enExample) |
| BR (2) | BR112014031796A2 (enExample) |
| CA (3) | CA2875302A1 (enExample) |
| IL (2) | IL236021A0 (enExample) |
| IN (1) | IN2015DN01780A (enExample) |
| SG (2) | SG11201408808WA (enExample) |
| WO (3) | WO2014046744A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220023503A9 (en) | 2007-05-10 | 2022-01-27 | Aziyo Med, Llc | Extracellular Matrix Tissue Prostheses |
| US20080279833A1 (en) | 2007-05-10 | 2008-11-13 | Matheny Robert G | Laminate sheet articles for tissue regeneration |
| US9283302B2 (en) | 2011-12-16 | 2016-03-15 | Cormatrix Cardiovascular, Inc. | Extracellular matrix encasement structures and methods |
| ES2553762T3 (es) * | 2009-02-18 | 2015-12-11 | Cormatrix Cardiovascular, Inc. | Composiciones y métodos para prevenir la arritmia cardiaca |
| EP2598181B1 (en) | 2010-07-31 | 2021-04-21 | Cook Medical Technologies LLC | Collagenous tissue pocket for an implantable medical device, and manufacturing method therefor |
| CN107206084B (zh) * | 2014-11-10 | 2021-05-14 | 伊井正明 | 用于增强干细胞功能的内含抑制素纳米粒子制剂以及含有其的功能增强干细胞及其制备方法 |
| US20160143720A1 (en) * | 2014-11-26 | 2016-05-26 | Cormatrix Cardiovascular, Inc. | Mesh Fiber Members and Methods for Forming and Using Same for Treating Damaged Biological Tissue |
| US20160143738A1 (en) * | 2014-11-26 | 2016-05-26 | Cormatrix Cardiovascular, Inc. | Biological Constructs for Treating Damaged Organs and Tissue |
| WO2016093863A1 (en) * | 2014-12-10 | 2016-06-16 | Cormatrix Cardiovascular, Inc. | Method and system for treatment of damaged biological tissue |
| EP3302594B1 (en) * | 2015-06-03 | 2024-09-11 | Wisconsin Alumni Research Foundation | Cardiac fibroblast-derived extracellular matrix and injectable formulations thereof for treatment of ischemic disease or injury |
| US11331348B2 (en) | 2016-04-28 | 2022-05-17 | University of Pittsburgh—of the Commonwealth System of Higher Education | Compositions comprising extracellular matrix of primitive animal species and related methods |
| CA3010717A1 (en) | 2016-07-11 | 2018-01-18 | Cormatrix Cardiovascular, Inc. | Prosthetic tissue valves |
| KR101710615B1 (ko) * | 2016-09-07 | 2017-02-27 | 주식회사 파마리서치프로덕트 | 생착률을 증가시킨 이식용 진피층 및 이의 제조 방법 |
| WO2019241910A1 (zh) * | 2018-06-19 | 2019-12-26 | 中国医学科学院阜外医院 | 基于药物预处理的间充质干细胞来源外泌体的制备方法 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5275826A (en) * | 1992-11-13 | 1994-01-04 | Purdue Research Foundation | Fluidized intestinal submucosa and its use as an injectable tissue graft |
| US6485723B1 (en) * | 1995-02-10 | 2002-11-26 | Purdue Research Foundation | Enhanced submucosal tissue graft constructs |
| CA2267449C (en) * | 1996-11-05 | 2008-10-14 | Purdue Research Foundation | Myocardial graft constructs |
| US6375989B1 (en) * | 1996-12-10 | 2002-04-23 | Purdue Research Foundation | Submucosa extracts |
| CA2274033C (en) * | 1996-12-10 | 2010-05-11 | Purdue Research Foundation | Biomaterial derived from vertebrate liver tissue |
| IL139708A0 (en) * | 2000-11-15 | 2002-02-10 | Amiel Gilad | Process of decellularizing biological matrices and acellular biological matrices useful in tissue engineering |
| WO2003007790A2 (en) * | 2001-07-16 | 2003-01-30 | Depuy Products, Inc. | Hybrid biologic/synthetic porous extracellular matrix scaffolds |
| US20040078090A1 (en) * | 2002-10-18 | 2004-04-22 | Francois Binette | Biocompatible scaffolds with tissue fragments |
| US20040175366A1 (en) * | 2003-03-07 | 2004-09-09 | Acell, Inc. | Scaffold for cell growth and differentiation |
| WO2004110427A1 (en) * | 2003-06-18 | 2004-12-23 | Institut De Cardiologie De Montréal /Montréal Heart Institute | Preventing atrial fibrillation (af) with the use of statin drugs |
| AU2004253508A1 (en) * | 2003-06-25 | 2005-01-13 | Acell, Inc. | Conditioned matrix compositions for tissue restoration |
| FI20045223L (fi) * | 2004-06-15 | 2005-12-16 | Bioretec Oy | Monitoiminen biohajoava komposiitti ja kirurginen implantti, joka käsittää mainitun komposiitin |
| US20050013870A1 (en) * | 2003-07-17 | 2005-01-20 | Toby Freyman | Decellularized extracellular matrix of conditioned body tissues and uses thereof |
| AU2004270239C1 (en) * | 2003-09-04 | 2011-07-07 | Cook Biotech Incorporated | Extracellular matrix composite materials, and manufacture and use thereof |
| WO2006102063A2 (en) * | 2005-03-19 | 2006-09-28 | Cook Biotech Incorporated | Prosthetic implants including ecm composite material |
| US20060293760A1 (en) * | 2005-06-24 | 2006-12-28 | Dedeyne Patrick G | Soft tissue implants with improved interfaces |
| US8568761B2 (en) * | 2005-07-15 | 2013-10-29 | Cormatrix Cardiovascular, Inc. | Compositions for regenerating defective or absent myocardium |
| US9532943B2 (en) * | 2010-12-20 | 2017-01-03 | Cormatrix Cardiovascular, Inc. | Drug eluting patch for the treatment of localized tissue disease or defect |
| WO2008021127A2 (en) * | 2006-08-08 | 2008-02-21 | Howmedica Osteonics Corp. | Expandable cartilage implant |
| US8361503B2 (en) * | 2007-03-02 | 2013-01-29 | University of Pittsburgh—of the Commonwealth System of Higher Education | Extracellular matrix-derived gels and related methods |
| WO2009086483A2 (en) * | 2007-12-26 | 2009-07-09 | Gel-Del Technologies, Inc. | Biocompatible protein particles, particle devices and methods thereof |
| WO2009086499A2 (en) | 2007-12-28 | 2009-07-09 | Cook Biotech Incorporated | Medical composition including an extracellular matrix particulate |
| JP2010059235A (ja) * | 2008-09-01 | 2010-03-18 | Fujifilm Corp | 紫外線吸収剤組成物 |
| ES2628100T3 (es) * | 2008-09-30 | 2017-08-01 | The Regents Of The University Of California | Composiciones que comprenden matriz extracelular descelularizada obtenida a partir de tejido cardíaco |
| ES2553762T3 (es) | 2009-02-18 | 2015-12-11 | Cormatrix Cardiovascular, Inc. | Composiciones y métodos para prevenir la arritmia cardiaca |
-
2012
- 2012-09-24 US US13/573,569 patent/US9072816B2/en active Active
-
2013
- 2013-05-01 US US13/874,942 patent/US20140087000A1/en not_active Abandoned
- 2013-05-29 WO PCT/US2013/043087 patent/WO2014046744A1/en not_active Ceased
- 2013-05-29 JP JP2015533045A patent/JP2015532922A/ja active Pending
- 2013-05-29 EP EP13838953.1A patent/EP2887948A4/en not_active Withdrawn
- 2013-05-29 AU AU2013318632A patent/AU2013318632A1/en not_active Abandoned
- 2013-05-29 SG SG11201408808WA patent/SG11201408808WA/en unknown
- 2013-05-29 BR BR112014031796A patent/BR112014031796A2/pt not_active IP Right Cessation
- 2013-05-29 CN CN201380049450.3A patent/CN104703614A/zh active Pending
- 2013-05-29 CA CA2875302A patent/CA2875302A1/en not_active Abandoned
- 2013-06-14 CA CA2883885A patent/CA2883885A1/en not_active Abandoned
- 2013-06-14 SG SG11201501649TA patent/SG11201501649TA/en unknown
- 2013-06-14 EP EP13839300.4A patent/EP2897623A4/en not_active Withdrawn
- 2013-06-14 JP JP2015533049A patent/JP2015531664A/ja active Pending
- 2013-06-14 WO PCT/US2013/046041 patent/WO2014046753A2/en not_active Ceased
- 2013-06-14 BR BR112015006512A patent/BR112015006512A2/pt not_active IP Right Cessation
- 2013-06-14 AU AU2013318552A patent/AU2013318552A1/en not_active Abandoned
- 2013-06-15 JP JP2015533048A patent/JP2015532923A/ja active Pending
- 2013-06-15 EP EP13839811.0A patent/EP2897624A4/en not_active Withdrawn
- 2013-06-15 WO PCT/US2013/046039 patent/WO2014046752A1/en not_active Ceased
- 2013-06-15 CA CA2884959A patent/CA2884959C/en not_active Expired - Fee Related
- 2013-06-15 AU AU2013318551A patent/AU2013318551B2/en not_active Ceased
-
2014
- 2014-12-01 IL IL236021A patent/IL236021A0/en unknown
- 2014-12-17 US US14/573,017 patent/US20150099007A1/en not_active Abandoned
-
2015
- 2015-03-04 IN IN1780DEN2015 patent/IN2015DN01780A/en unknown
- 2015-03-04 IL IL237568A patent/IL237568A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015532923A5 (enExample) | ||
| JP2011256183A5 (enExample) | ||
| CL2009000426A1 (es) | Compuestos derivados de carbociclil/heterociclil-piridin-2-il-urea, inhibidores de topoisomerasa iv bacteriana; composicion farmaceutica; y su uso para el tratamiento de infecciones bacterianas | |
| EA033311B1 (ru) | Производные бензоксаборола в качестве антибактериальных средств | |
| CL2014000468A1 (es) | Compuestos derivados del acido 2-oxo-6-(fenil/heteroaril)l-1,2-dihidropiridin-3-carboxilico; composicion farmaceutica; combinacion; y su uso para el alivio de una infeccion bacteriana. | |
| WO2015024010A3 (en) | Substituted hydroxamic acid compounds | |
| BR112013015796A2 (pt) | composição de agente de formação de imagem, método de preparar uma composição de agente de formação de imagem, método de preparar um quelante 18f-nota, e, composição farmacêutica. | |
| CL2012003722A1 (es) | Compuestos derivados del acido naf-2-ilacetico; composicion farmaceutica; y uso para el tratamiento del sida. | |
| WO2013122888A3 (en) | Methods of treating bacterial infections | |
| BR112014030649A2 (pt) | inibidores macrocíclicos da flaviviridae vírus | |
| EP2662353A3 (en) | Antibacterial agents | |
| BR112013015010A2 (pt) | produto, substrato, composição farmacêutica, uso de um produto, e, método para tratar uma infecção microbiana | |
| ZA201105290B (en) | Antibiotic compositions for the treatment of gram negative infections | |
| EP2953624A4 (en) | METHOD FOR THE TREATMENT OF MICROBIAL INFECTIONS, INCLUDING MASTITIS | |
| WO2015066302A3 (en) | Compositions, methods of use, and methods of treatment | |
| EP2217211A4 (en) | ORAL ABSORBENT SOLID DOSAGE FORMULATION FOR VANCOMYCIN | |
| CL2014001154A1 (es) | Compuestos derivados antibioticos de 2-oxo-oxazolidin-3,5-diilo de formula i; composicion farmaceutica; uso para la prevencion o tratamiento de una infeccion bacteriana. | |
| CL2014001861A1 (es) | Compuestos derivados de bencil sulfonamida, inhibidores de mogat-2; compuesto cristalino; composicion farmaceutica; y su uso en el tratamiento de la hipertrigliceridemia. | |
| DOP2010000373A (es) | Derivados de urea heterociclicos para el tratamiento de infecciones bacterianas | |
| CL2008000110A1 (es) | Uso de compuestos derivados de piranona sustituidos para el tratamiento del sindrome metabolico; y compuestos derivados de piranona sustituidos. | |
| BR112013015798A2 (pt) | composição de agente de formação de imagem, método de preparar uma composição de agente de formação de imagem, e, composição farmacêutica | |
| EP3150631C0 (en) | PASSIVE ANTI-GLUCOSAMINIDASE IMMUNIZATION FOR STAPHYLOCOCCUS AUREUS INFECTIONS | |
| HK1210825A1 (en) | Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk | |
| LT3820856T (lt) | C-manozido junginiai, naudingi šlapimo takų infekcijoms gydyti | |
| MX2017003011A (es) | Metodo para usar derivado de acido hidroxamico novedoso y sustancia antibacterial en combinacion. |